FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SterRx Norepinephrine 8 mg per 250 mL Recall

Norepinephrine 8 mg per 250 mL (32 mcg per mL) in 0

SterRx, LLC · Plattsburgh, NY

Risk level
Class II
Reported by FDA
Jul 26, 2023
Recall ID
D-0932-2023
Check your lot numberHow we source this data

Summary

SterRx recalled Norepinephrine 8 mg per 250 mL starting Jul 7, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0932-2023 on Jul 26, 2023. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

Norepinephrine 8 mg per 250 mL (32 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-577-01.

Lot numbers, UPCs & expiration codes

Lot #: 490071, Exp 30-Jul-23; 490089, Exp 4-Aug-23; 490118, 490126, Exp 5-Aug-23; 490169, Exp 10-Aug-23; 491276, Exp 11-Aug-23; 491284, Exp 12-Aug-23; 491612, Exp 18-Aug-23; 497467, Exp 8-Dec-23; 497475, Exp 9-Dec-23; 499104, Exp 18-Jan-24; 499112, Exp 19-Jan-24; 499121, 499278, Exp 20-Jan-24; 499358, Exp 21-Jan-24; 502019, Exp 24-Mar-24; 502027, Exp 29-Mar-24; 502035, Exp 5-Apr-24; 503513, Exp 18-Apr-24; 504217, Exp 20-Apr-24

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0932-2023
Classification
Class II
Status
Terminated
Recall initiated
Jul 7, 2023
FDA report date
Jul 26, 2023
Quantity
125,598 bags
Recall type
Voluntary: Firm initiated
Recalling firm
SterRx, LLC

Original FDA data

Every field from FDA enforcement report D-0932-2023, exactly as published.

Show all FDA fields
City
Plattsburgh
State
NY
Status
Terminated
Country
United States
Event ID
92657
Address
141 Idaho Ave
Code information
Lot #: 490071, Exp 30-Jul-23; 490089, Exp 4-Aug-23; 490118, 490126, Exp 5-Aug-23; 490169, Exp 10-Aug-23; 491276, Exp 11-Aug-23; 491284, Exp 12-Aug-23; 491612, Exp 18-Aug-23; 497467, Exp 8-Dec-23; 497475, Exp 9-Dec-23; 499104, Exp 18-Jan-24; 499112, Exp 19-Jan-24; 499121, 499278, Exp 20-Jan-24; 499358, Exp 21-Jan-24; 502019, Exp 24-Mar-24; 502027, Exp 29-Mar-24; 502035, Exp 5-Apr-24; 503513, Exp 18-Apr-24; 504217, Exp 20-Apr-24
Postal code
12903-3987
Report date
Jul 26, 2023
Product type
Drugs
Recall number
D-0932-2023
Classification
Class II
Recalling firm
SterRx, LLC
Product quantity
125,598 bags
Termination date
Jul 8, 2024
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Norepinephrine 8 mg per 250 mL (32 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-577-01.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jul 7, 2023
Initial firm notification
Letter
Center classification date
Jul 19, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0932-2023, published Jul 26, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls